In line with this, down-regulation of CD73 expression via clustered regularly interspaced short palindromic repeats interference (CRISPRi) (targeting the p30-bound enhancer) or RNA-interference significantly extended survival in a mouse model of CEBPA-mutated AML. The gene discussed is CEBPA; the disease is acute myeloid leukemia.